{"article": [{"url": "https://www.marketwatch.com/story/kronos-bios-stock-opens-tk-above-ipo-price-2020-10-09", "published": 1602245360.0, "headline": "Kronos Bio's stock opens 50% above IPO price", "body": "Shares of Kronos Bio Inc. KRON, +42.47% soared in their public debut, as they opened 50% above the initial public offering price. The stock's first trade was at $28.50 at 11:58 a.m. Eastern for 673,799 shares. The IPO was priced at $19 a share, above the expected range of $16 to $18 a share. The California-based biotechnology company raised $250.8 million in the IPO, and the pricing valued the company at about $1.03 billion. The stock has edged higher since its open, to be 53% above its IPO price in recent trading. Meanwhile, the Renaissance IPO ETF IPO, +1.98% was rising 1.8% and the S&P 500 SPX, +0.87% was climbing 1.0%."}]}